A biotech seeking IPO riches delayed revealing patient deaths tied to immunotherapy – STAT
STAT |
A biotech seeking IPO riches delayed revealing patient deaths tied to immunotherapy
STAT rivate biotechs are like Instagram posts. The glossy, successful image they choose to share can hide darker truths. So it's been with Unum Therapeutics, a buzzy T-cell cancer immunotherapy startup backed by a roster of powerful investors, including the … |
